eli lilly's tirzepatide is the leader in weight loss sector A new drug website just launched by Lilly Ozempic maker Novo Nordisk sues

SKU: 72969008050

Pay in 4 interest-free payments of $6.24 Learn more

Live Spec

Ozempic maker Novo Nordisk sues US rival over 'materially misleading' ads Pharmaceuticals industry The Guardian Lilly's Zepbound tops Wegovy for weight loss in head to head trial Reuters The FDA says the Zepbound shortage is over. That's rattling the weight loss industry Zepbound results in more weight loss than Wegovy in trial, Eli Lilly says Lilly wins NICE endorsement for tirzepatide in obesitywith a catch Fierce Pharma It is interesting to see the kind of communication narratives adopted by weight loss drug makers Lilly (Mounjaro Tirzepatide) and Novo Nordisk (Wegovy). Both are selling the same story, but I like Novo

Store: chezloetli.be · Domain: chezloetli.be